Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HOOKIPA Pharma Inc. (HOOK)
|
Add to portfolio |
|
|
|
| Price: |
$2.23
| | Metrics |
| OS: |
84.0
|
M
| |
-61
|
% ROE
|
| Market cap: |
$187
|
M
| |
-464
|
% ROIC
|
|
Net cash:
|
$135
|
M
| |
$1.60
|
per share
|
|
EV:
|
$52.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($75.3)
|
M
| |
|
|
|
EBIT
|
($78.7)
|
M
| |
|
|
| EPS |
($0.93)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 14.2 | 18.4 | 19.6 | 11.9 | 7.6 | 0.0 |
| Revenue growth | -22.8% | -5.8% | 64.0% | 56.5% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 14.2 | 18.4 | 19.6 | 11.9 | 7.6 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Research and development | 68.6 | 82.9 | 54.8 | 46.3 | 22.0 | 9.8 |
| General and administrative | 18.8 | 17.3 | 18.1 | 16.7 | 6.8 | 4.4 |
| EBIT | -73.2 | -81.7 | -53.3 | -51.1 | -21.2 | -14.2 |
| EBIT margin | -513.4% | -442.7% | -272.1% | -427.8% | -277.6% | |
| Pre-tax income | -64.7 | -75.7 | -44.1 | -43.0 | -16.2 | -12.7 |
| Income taxes | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | | |
| Net income | -64.9 | -75.7 | -44.1 | -43.0 | -16.2 | -12.7 |
| Net margin | -455.6% | -410.2% | -225.1% | -360.4% | -212.8% | |
| |
| Diluted EPS | ($0.99) | ($2.30) | ($1.69) | ($2.41) | ($17.76) | ($13.95) |
| Shares outstanding (diluted) | 65.5 | 32.8 | 26.0 | 17.9 | 0.9 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|